fda crackdown on compounded semaglutide Intensifies GLP-1 Compounding FDA restricts non-approved compounded GLP-1

Side Effects: Higher potency may lead to increased risk of side effects

It has been reported to have a wide range of health-boosting effects, including the prevention of diseases such as diabetes, inflammation, cancer, stroke, neurodegeneration, and aging [85,202]

It can be considered a very good option for regular methylcobalamin therapy

Acknowledgments The authors would like to acknowledge the Department of Biomedical Sciences, Faculty of Medicine and Medical Sciences, University of Balamand, Al-Koura, Lebanon

, Bhol N

In order to find miRs that potentially target ARR1, the authors utilized a bioinformatics technique